Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gerken

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Head & Neck|October 28, 2024
Increased PD-1/PD-L1 Immune Checkpoint Expression Is Associated With Oral Squamous Cell Carcinoma in Never-Smokers and Never-DrinkersMathias Fiedler, Alisa Off, Andreas Gärtner, et al.
BMC Cancer|January 26, 2026
The effects of certification of head and neck cancer centers on the survival of patients with a head and neck cancerOlaf Schoffer, Max Kemper, Michael Gerken, et al.
BMC Psychology|September 11, 2020
Single-institution cross-sectional study to evaluate need for information and need for referral to psychooncology care in association with depression in brain tumor patients and their family caregiversChristiane Reinert, Michael Gerken, Katharina Rathberger, et al.
Cancers|February 11, 2023
A20 as a Potential New Tool in Predicting Recurrence and Patient's Survival in Oral Squamous Cell CarcinomaSteffen Spoerl, Ramona Erber, Michael Gerken, et al.
Neuro-Oncology Advances|November 4, 2024
Effect of antibiotic drug use on outcome and therapy-related toxicity in patients with glioblastoma-A retrospective cohort studyLinda Götz, Tananeh Ansafi, Michael Gerken, et al.
BMC Cancer|June 7, 2022
Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort studyMartin Roessler, Jochen Schmitt, Christoph Bobeth, et al.
Journal of Cancer Research and Clinical Oncology|January 6, 2020
Long-term outcome of patients with intermediate- and high-risk endometrial cancer after pelvic and paraaortic lymph node dissection: a comparison of laparoscopic vs. open procedureThomas Papathemelis, Helen Oppermann, Stella Grafl, et al.
Oral Oncology|May 11, 2020
Prognostic value of perioperative red blood cell transfusion and anemia on survival and recurrence in oral squamous cell carcinomaGerrit Spanier, Janika Böttcher, Michael Gerken, et al.
Journal of Neuro-Oncology|July 21, 2025
Dietary habits in relation to outcome and therapy-related toxicity in patients with glioblastoma - a retrospective cohort studyTareq M Haedenkamp, Linda Götz, Tananeh Ansafi, et al.
Head & Neck|May 10, 2026
A Comprehensive Immune Checkpoint Phenotype Predicts Response and Survival to PD-1 Blockade in Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaMathias Fiedler, Lea Baumann, Jonas Eichberger, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Head & Neck|October 28, 2024
Increased PD-1/PD-L1 Immune Checkpoint Expression Is Associated With Oral Squamous Cell Carcinoma in Never-Smokers and Never-DrinkersMathias Fiedler, Alisa Off, Andreas Gärtner, et al.
BMC Cancer|January 26, 2026
The effects of certification of head and neck cancer centers on the survival of patients with a head and neck cancerOlaf Schoffer, Max Kemper, Michael Gerken, et al.
BMC Psychology|September 11, 2020
Single-institution cross-sectional study to evaluate need for information and need for referral to psychooncology care in association with depression in brain tumor patients and their family caregiversChristiane Reinert, Michael Gerken, Katharina Rathberger, et al.
Cancers|February 11, 2023
A20 as a Potential New Tool in Predicting Recurrence and Patient's Survival in Oral Squamous Cell CarcinomaSteffen Spoerl, Ramona Erber, Michael Gerken, et al.
Neuro-Oncology Advances|November 4, 2024
Effect of antibiotic drug use on outcome and therapy-related toxicity in patients with glioblastoma-A retrospective cohort studyLinda Götz, Tananeh Ansafi, Michael Gerken, et al.
BMC Cancer|June 7, 2022
Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort studyMartin Roessler, Jochen Schmitt, Christoph Bobeth, et al.
Journal of Cancer Research and Clinical Oncology|January 6, 2020
Long-term outcome of patients with intermediate- and high-risk endometrial cancer after pelvic and paraaortic lymph node dissection: a comparison of laparoscopic vs. open procedureThomas Papathemelis, Helen Oppermann, Stella Grafl, et al.
Oral Oncology|May 11, 2020
Prognostic value of perioperative red blood cell transfusion and anemia on survival and recurrence in oral squamous cell carcinomaGerrit Spanier, Janika Böttcher, Michael Gerken, et al.
Journal of Neuro-Oncology|July 21, 2025
Dietary habits in relation to outcome and therapy-related toxicity in patients with glioblastoma - a retrospective cohort studyTareq M Haedenkamp, Linda Götz, Tananeh Ansafi, et al.
Head & Neck|May 10, 2026
A Comprehensive Immune Checkpoint Phenotype Predicts Response and Survival to PD-1 Blockade in Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaMathias Fiedler, Lea Baumann, Jonas Eichberger, et al.
Pageof 18